Robotic segmentectomy for early-stage lung cancer
- PMID: 37035569
- PMCID: PMC10076657
- DOI: 10.3389/fsurg.2023.1090080
Robotic segmentectomy for early-stage lung cancer
Abstract
Lobectomies have long been the gold standard for surgical treatment of early-stage non-small cell lung cancer (NSCLC), with segmentectomies limited to instances of benign disease or as an alternative in patients where lung preservation is indicated. However, a recently published randomized control trial has demonstrated the superiority of segmentectomy over lobectomy in terms of overall survival for early-stage lung cancer. Segmentectomy could thus be considered a standard procedure for small-sized peripheral NSCLC. While segmentectomy via video-assisted thoracic surgery (VATS) is the most widespread approach, development in video instrumentation and thoracic robotic surgery is rapidly gaining interest. Indeed, robotic surgery pioneers boast the advantages in three-dimensional view, improved magnification, ergonomics, dexterity, safety, and ease of surgery with this technology. This review aims to outline robotic-assisted segmentectomy indications, preoperative evaluation, and the operative conduct for the different lung segments from a single surgeon console. There are many ways to perform segmentectomies and therefore this review describes generalized approaches that can be tailored based on experience.
Keywords: lobectomy; lung cancer; non-small cell lung cancer; robotic-assisted surgery; segmentectomy.
© 2023 Savonitto, Yasufuku and Wallace.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




References
-
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Small Cell Lung Cancer (Version 5.2022). https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf (October 26, 2022).
-
- Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, et al. West Japan oncology group and Japan clinical oncology group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. (2022) 399(10335):1607–17. 10.1016/S0140-6736(21)02333-3 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources